Bookmark

Add to MyYahoo RSS

Axcan Pharma News

News on Axcan Pharma (Ticker: AXCA) continually updated from thousands of sources around the net.

Jan 8, 2014 | Investor's Business Daily

Forest Buying Aptalis; Teva Bids For NuPathe Vs. Endo

Forest Labs agreed to pay $2.9 billion for Aptalis, a drugmaker that filed to go public on Dec. 26 after a major reworking by the private equity group TPG Capital.

Comment?

Related Topix: Biotech

Thu Dec 26, 2013

Investor's Business Daily

Drugmaker Aptalis Files For IPO After Overhaul

Drugmaker Aptalis Holdings filed to go public Thursday in an IPO expected to raise around half a billion dollars, as the company formerly traded as Axcan Pharma returns in a new incarnation.

Comment?

Related Topix: Biotech, Ulcer, Medicine, Health

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••